PMH15 COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RISPERIDONE (LA-RIS) VS HALOPERIDOL DECANOATE AND ORAL OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA IN ITALY

Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61772-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)61772-X/fulltext
Section Title :
Section Order : 217
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61772-X&doi=10.1016/S1098-3015(10)61772-X
HEOR Topics :
Tags :
Regions :